High prevalence of Mycobacterium avium subspecies paratuberculosis IS 900 DNA in gut tissues from individuals with Crohn’s disease
Authors:
Open Access
Abstract
Background and aims: Conflicting results exist about the presence of Mycobacterium avium subspecies paratuberculosis (MAP) specific IS 900 DNA in Crohn’s disease (CD) tissues. Therefore, we examined IS 900 in a large number of gut samples from patients with CD (n = 100) and ulcerative colitis (UC, n = 100), and in non-inflamed control tissues (nIBD, n = 100). We hypothesised that IS 900 DNA detection might be associated with distinct clinical phenotypic characteristics in CD. Methods: The prevalence of MAP DNA in surgically resected tissues was examined using a mechanical-enzymatic disruption technique and nested IS 900 specific polymerase chain reaction (PCR). CD patients were stratified according to the criteria of the Vienna classification and other clinical characteristics. Results: IS 900 PCR detection rate was significantly higher in CD tissue samples (52%) than in UC (2%) or nIBD (5%) specimens (p900 DNA was detected in samples from both diseased small bowel (47%) as well as from the colon (61%). No firm association between MAP specific IS 900 detection rates and clinical phenotypic characteristics in CD could be established. However, corticosteroid medication constituted a factor which tended to have a negative influence on IS 900 DNA detection rates in CD (pConclusions: The presence of MAP specific IS 900 DNA is a predominant feature of CD. Therapeutic intervention against MAP might represent a potential target for disease mitigation in Crohn’s disease.Keywords
This publication has 33 references indexed in Scilit:
- Study of Animal-Borne Infections in the Mucosas of Patients with Inflammatory Bowel Disease and Population-Based ControlsJournal of Clinical Microbiology, 2003
- PCR detection of Mycobacterium paratuberculosis in Crohn’s disease granulomas isolated by laser capture microdissectionGut, 2002
- Treatment of severe Crohn's disease using antimycobacterial triple therapy — approaching a cure?Digestive and Liver Disease, 2002
- Open clinical trial of rifabutin and clarithromycin therapy in Crohn's diseaseDigestive and Liver Disease, 2002
- Identification of Mycobacterium avium subsp. paratuberculosis in Biopsy Specimens from Patients with Crohn's Disease Identified by In Situ HybridizationJournal of Clinical Microbiology, 2001
- Detection of Mycobacterium avium Subspecies paratuberculosis in Crohn's Diseased Tissues by In Situ HybridizationAmerican Journal of Gastroenterology, 2001
- Sensitive Differential Detection of Genetically Related Mycobacterial Pathogens in Archival MaterialAmerican Journal of Clinical Pathology, 2000
- Identification of cell wall deficient forms of M. avium subsp. paratuberculosis in paraffin embedded tissues from animals with Johne’s disease by in situ hybridizationJournal of Microbiological Methods, 2000
- Mycobacterium paratuberculosis and Crohn's disease.Gut, 1995
- Nitric oxide synthase in gastric mucosa.Gut, 1995